| Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells G Du, H Lin, M Wang, S Zhang, X Wu, L Lu, L Ji, L Yu Cancer chemotherapy and pharmacology 65, 277-287, 2010 | 156 | 2010 |
| Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer J Yang, Y Gong, VK Lam, Y Shi, Y Guan, Y Zhang, L Ji, Y Chen, Y Zhao, ... Cell death & disease 11 (5), 346, 2020 | 144 | 2020 |
| Longitudinal undetectable molecular residual disease defines potentially cured population in localized non–small cell lung cancer JT Zhang, SY Liu, W Gao, SYM Liu, HH Yan, L Ji, Y Chen, Y Gong, HL Lu, ... Cancer Discovery 12 (7), 1690-1701, 2022 | 132 | 2022 |
| Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4 S Lv, L Ji, B Chen, S Liu, C Lei, X Liu, X Qi, Y Wang, E Lai-Han Leung, ... Oncogene 37 (10), 1354-1368, 2018 | 125 | 2018 |
| Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice G Du, H Lin, Y Yang, S Zhang, X Wu, M Wang, L Ji, L Lu, L Yu, G Han International immunopharmacology 10 (7), 819-826, 2010 | 94 | 2010 |
| Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1α inhibition G Du, G Han, S Zhang, H Lin, X Wu, M Wang, L Ji, L Lu, L Yu, W Liang European journal of pharmacology 630 (1-3), 121-130, 2010 | 83 | 2010 |
| Molecular characterization of HBV DNA integration in patients with hepatitis and hepatocellular carcinoma L Yang, S Ye, X Zhao, L Ji, Y Zhang, P Zhou, J Sun, Y Guan, Y Han, C Ni, ... Journal of Cancer 9 (18), 3225, 2018 | 70 | 2018 |
| Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning J Huang, Z Qian, Y Gong, Y Wang, Y Guan, Y Han, X Yi, W Huang, L Ji, ... Journal of medical genetics 56 (3), 186-194, 2019 | 69 | 2019 |
| Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization Y Kou, L Ji, H Wang, W Wang, H Zheng, J Zou, L Liu, X Qi, Z Liu, B Du, ... International Journal of Cancer 141 (8), 1690-1703, 2017 | 65 | 2017 |
| Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review Z Huang, Q Huang, L Ji, Y Wang, X Qi, L Liu, Z Liu, L Lu Pharmacological Research 114, 1-12, 2016 | 51 | 2016 |
| Prevention of wogonin on colorectal cancer tumorigenesis by regulating p53 nuclear translocation Q Feng, H Wang, J Pang, L Ji, J Han, Y Wang, X Qi, Z Liu, L Lu Frontiers in pharmacology 9, 1356, 2018 | 45 | 2018 |
| Senescence inducer shikonin ROS-dependently suppressed lung cancer progression H Zheng, Q Huang, S Huang, X Yang, T Zhu, W Wang, H Wang, S He, L Ji, ... Frontiers in pharmacology 9, 519, 2018 | 41 | 2018 |
| Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer H Zhou, Y Hu, R Luo, Y Zhao, H Pan, L Ji, T Zhou, L Zhang, H Long, J Fu, ... Nature communications 12 (1), 5431, 2021 | 40 | 2021 |
| Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents J Yang, S Yang, S Zhou, D Lu, L Ji, Z Li, S Yu, X Meng European Journal of Medicinal Chemistry 122, 488-496, 2016 | 40 | 2016 |
| Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors C Zhang, S Li, L Ji, S Liu, Z Li, S Li, X Meng Bioorganic & Medicinal Chemistry Letters 25 (20), 4693-4696, 2015 | 35 | 2015 |
| DACT2 epigenetic stimulator exerts dual efficacy for colorectal cancer prevention and treatment L Lu, Y Wang, R Ou, Q Feng, L Ji, H Zheng, Y Guo, X Qi, ANT Kong, Z Liu Pharmacological Research 129, 318-328, 2018 | 34 | 2018 |
| Synthesis and structure–activity relationship of 4-azaheterocycle benzenesulfonamide derivatives as new microtubule-targeting agents J Yang, S Zhou, L Ji, C Zhang, S Yu, Z Li, X Meng Bioorganic & medicinal chemistry letters 24 (21), 5055-5058, 2014 | 27 | 2014 |
| The novel triazolonaphthalimide derivative LSS-11 synergizes the anti-proliferative effect of paclitaxel via STAT3-dependent MDR1 and MRP1 downregulation in chemoresistant lung … L Ji, X Liu, S Zhang, S Tang, S Yang, S Li, X Qi, S Yu, L Lu, X Meng, Z Liu Molecules 22 (11), 1822, 2017 | 26 | 2017 |
| Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy P Tian, H Zeng, L Ji, Z Ding, L Ren, W Gao, Z Fan, L Li, X Le, P Li, ... Lung Cancer 160, 50-58, 2021 | 20 | 2021 |
| Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma F Wang, X Xie, M Song, L Ji, M Liu, P Li, Y Guan, X Lin, Y Qin, Z Xie, ... Annals of Translational Medicine 8 (12), 2020 | 17 | 2020 |
